Miedo (excesivo)

Apigenin, a flavone in parsley, celery, and chamomile, demonstrates xanthine oxidase inhibitory activity comparable to allopurinol in laboratory studies. Multiple in vitro studies consistently rank it among the most potent natural XO inhibitors. Hepatocyte culture studies confirm dose-dependent reduction of uric acid production. Animal studies show serum uric acid reduction in hyperuricemic models.

Ashitaba chalcones are documented xanthine oxidase (XO) inhibitors in vitro; XO is the enzyme that produces uric acid and is the target of allopurinol. Xanthoangelol was identified as the most potent XO inhibitor among A. keiskei phenolics. Gout is also listed as a traditional use in Japanese folk medicine.

Chinese folk medicine specifically recorded asparagus for preventing and treating gout, and asparagus appears in traditional European pharmacopoeias for gout and rheumatism. A 2025 PMC-indexed study evaluated mature green asparagus stem as a dietary supplement for hyperuricemia in animal models, finding asparagus ameliorates hyperuricemia by regulating hepatic uric acid metabolism and renal uric acid excretion.

Atractylodes macrocephala has been specifically studied in preclinical hyperuricemia and gouty arthritis rat models. It reduced serum uric acid, xanthine oxidase activity, and inflammatory cytokines, with an anti-inflammatory mechanism linked to AMPK/SIRT1 and NF-κB inhibition.

Banaba leaf extract and two of its isolated polyphenols—valoneic acid dilactone (VAD) and ellagic acid (EA)—have demonstrated xanthine oxidase (XOD) inhibitory activity in vitro, with VAD showing stronger inhibition than allopurinol in one bioassay. This mechanistic evidence links banaba to uric acid reduction relevant to gout, though human clinical trials are absent.

Sodium bicarbonate alkalinizes urine, raising pH and increasing solubility of uric acid, which can help reduce uric acid crystallization in gout patients. A clinical study showed urine pH rises from ~5.5 to ~6.0 with 1 g three times daily over three months in gout patients. However, the 2020 ACR Gout Guidelines caution against routine urine alkalinization with sodium bicarbonate due to risks of sodium loading, hypertension, and fluid retention.

Cherry, particularly tart (sour) cherry, has the strongest food-based evidence for gout management. A systematic review of six studies found cherry/cherry juice consistently reduced gout incidence and severity. A large case-crossover study (n=633 gout patients) found cherry intake over 2 days was associated with a 35% lower risk of gout attack, and cherry extract use lowered risk by 45%.

Animal studies show chokeberry suppresses serum uric acid levels, reduces xanthine oxidase activity, and inhibits inflammation associated with acute gout. A 2025 mouse study confirmed uric acid lowering via xanthine oxidase inhibition. Human clinical trial evidence is lacking; a 2022 Nutrients review confirmed uric acid-lowering effects require confirmation in humans.

Coix seed oil has been shown in a mouse hyperuricemia model to significantly reduce serum uric acid levels and ameliorate oxidative stress and gut microbiota dysbiosis associated with hyperuricemia. Coix is also included in TCM formulas traditionally used for gout.

Corn silk has traditionally documented uricosuric properties, confirmed in a controlled animal study where aqueous extract increased urinary uric acid excretion in rats. The diuretic action additionally facilitates renal excretion of uric acid, potentially reducing gout risk. Traditional use for gout is well-documented across multiple herbal traditions.

EGCG, the major catechin of green tea, specifically inhibits IL-1β expression, blocks ROS production, and limits leukocyte infiltration in MSU crystal-induced peritonitis models directly replicating acute gout inflammation. EGCG also suppresses NLRP3 inflammasome and NF-κB, key molecular drivers of gouty arthritis. Tea leaf extracts consistently show high XO inhibitory activity in comparative plant extract studies.

Folic acid has been studied as a potential xanthine oxidase inhibitor and uric acid-lowering agent. A 2022 animal study found folic acid intervention observably reduced uric acid and downregulated xanthine oxidase and adenosine deaminase activities in hyperuricemic rats. A pilot combination clinical trial including folic acid in chronic gout patients demonstrated reduced plasma uric acid and symptoms.

Ginger has been studied for hyperuricemia in humans, with a 2015 human study showing ginger supplementation lowered serum uric acid levels in people with hyperuricemia, and another study finding it reduced gout-associated inflammation and pain. Ginger's active compounds inhibit COX-1/COX-2 and 5-LOX pathways relevant to gout inflammation. 6-gingerol also shows moderate xanthine oxidase inhibitory activity in vitro.

Panax ginseng-containing traditional formula (Saengmaeksan) ameliorated hyperuricemia in animal studies by inhibiting xanthine oxidase activity and enhancing urate excretion. Ginsenosides also exhibit anti-inflammatory activity via NLRP3 inflammasome suppression. The MDPI 2024 review of herbal medications for gout includes Panax ginseng among evidence-supported herbs.

Green tea extracts, particularly EGCG and other catechins, have been studied for xanthine oxidase inhibitory activity and anti-inflammatory effects relevant to gout. Tea leaf extracts consistently show high XO inhibitory activity in comparative studies of plant extracts. EGCG inhibits IL-1β expression and blocks ROS production in MSU peritonitis models in animals.

Hibiscus sabdariffa (roselle) has demonstrated uricosuric effects in a clinical study of 18 subjects, finding that roselle calyx tea significantly increased urinary uric acid excretion and clearance. Animal studies show the extract inhibits xanthine oxidase and increases uricase activity, lowering serum uric acid more effectively than allopurinol in hyperuricemic rats. Anthocyanins regulate OAT1/OAT3 transporters to promote urate elimination.

Kaempferol is a dietary flavonol ranked among the most potent natural xanthine oxidase inhibitors in in vitro and in silico studies. In fructose-induced hyperuricemic rodents, kaempferol significantly reduced blood uric acid to levels equivalent to healthy controls. It also inhibits NF-κB and reduces inflammatory cytokines relevant to gout.

Clinical evidence from a pilot open trial found that 30 mL/day of fresh lemon juice for 6 weeks significantly reduced serum uric acid in hyperuricemic patients. The proposed mechanism is urinary alkalization via calcium carbonate stimulation, enhancing renal uric acid excretion.

Luteolin is a flavone confirmed as a competitive xanthine oxidase inhibitor in vitro, with inhibitory activity comparable to or exceeding quercetin. In animal models of hyperuricemic nephropathy, luteolin activated urate excretion via ABCG2 and OAT transporters, inhibited hepatic XO, and protected renal function. Hepatocyte culture studies show luteolin reduces uric acid production more potently than quercetin.

Lychee peel extract (LPE) significantly inhibits xanthine oxidase (XOD)—the key enzyme in uric acid synthesis—in vitro, and reduces uric acid levels in hyperuricemia mouse models by both inhibiting XOD activity and decreasing urate transporter (URAT1) expression. A human study with oligonol (lychee-derived) found significantly decreased 1-hour uric acid excretion and serum uric acid concentration, consistent with XOD inhibition.

Milk thistle's active silymarin complex, particularly silybin, is a confirmed mixed-type xanthine oxidase inhibitor in vitro that also reduces XO-generated superoxide. Animal studies from 2013 and 2016 found milk thistle extract may lower uric acid in rats with health conditions damaging the kidneys. The 2023 Food Frontiers review ranked silybin among flavonoids that decrease uric acid in hyperuricemic animals by more than 50% at certain doses.

Xanthine oxidase (XO), the molybdenum-dependent enzyme that catalyzes the final steps of purine catabolism to uric acid, is mechanistically central to gout. A large NHANES epidemiological study (n=15,370) found higher urinary molybdenum significantly associated with lower serum uric acid and reduced prevalence of hyperuricemia (OR 0.73) and gout (OR ~0.71). The relationship is both mechanistic and epidemiologically supported.

TC extract significantly reduced serum uric acid levels, ankle swelling, and inflammatory markers in a gout rat model by inhibiting xanthine oxidase, uric acid transporters, and NLRP3 inflammasome activation. TC is also recorded in the Tibetan 'Four Medical Tantras' as a core anti-gout remedy.

Stinging nettle (Urtica dioica) has traditional use for gout as a diuretic to promote uric acid excretion. A small 2025 human clinical study and a 2017 study found nettle may reduce uric acid levels in people with hyperuricemia or gout. Nettle's flavonoid constituents (quercetin, kaempferol) inhibit xanthine oxidase in vitro.

Omega-3 fatty acids from fish oil have been evaluated in a pilot randomized trial in gout patients (n=40), finding a statistically significant inverse correlation between red cell omega-3 concentrations and gout flare frequency (r=−0.75, p≤0.001). An earlier study suggested 2 g/day may decrease uric acid within a month. Omega-3s exert anti-inflammatory effects by modulating eicosanoid and leukotriene pathways relevant to gout inflammation.

Polyphenols isolated from P. orientalis leaves, including quercetin, apigenin, myricetin, kaempferol, and luteolin, have demonstrated xanthine oxidase inhibitory activity in molecular docking studies, directly relevant to uric acid reduction. A study also documented P. orientalis flavonoids as having anti-hyperuricemia activity. The plant is listed in systematic reviews as having anti-hyperuricemia properties.

P. foetida has documented antihyperuricemic activity in preclinical models, and has traditional use for gout in Vietnam and India. Network pharmacology and molecular docking studies have identified bioactive compounds and predicted targets within uric acid metabolism pathways.

In Iranian traditional medicine, parsley is specifically used for hyperuricaemia and gout. A controlled rat study demonstrated that oral parsley (5 g/kg) significantly reduced serum uric acid in oxonate-induced hyperuricaemic animals by inhibiting liver xanthine oxidoreductase, the enzyme responsible for uric acid production, while also improving antioxidant status.

Phyllanthus niruri (chanca piedra) inhibits xanthine oxidase in vitro, comparable in some assays to allopurinol. A clinical study of 56 kidney stone patients found urinary uric acid dropped following 12 weeks of P. niruri infusion in hyperuricosuria patients. Traditional use in Ayurvedic and South American medicine for excess uric acid and kidney stones is well-documented.

A dedicated pharmacological study (Ahmad et al., J Ethnopharmacol, 2008; PMID 18420362) tested P. integerrima leaf extracts for xanthine oxidase (XO) inhibition in vitro and uric acid lowering in a fructose-induced hyperuricemic mouse model, finding significant XO inhibitory activity (IC50 19–20 µg/ml) and meaningful serum uric acid reduction. Galls are also separately documented to lower uric acid in mice. Wikipedia's xanthine oxidase inhibitor article notes this plant warrants further research.

Queen of the meadow has pre-clinical scientific evidence for gout through demonstrated xanthine oxidase (XO) inhibitory activity—the same mechanism as allopurinol—published in peer-reviewed literature. Combined with diuretic action that promotes uric acid excretion, it has a well-supported mechanistic basis. Traditional use for gout is also extensively documented.

Quercetin competitively inhibits xanthine oxidase (XO), the enzyme responsible for uric acid production, via the same pathway targeted by allopurinol. A randomized, double-blinded, placebo-controlled crossover trial (Br J Nutr 2016) found 500 mg/day for 4 weeks significantly lowered plasma uric acid in pre-hyperuricemic males. Real-world clinical studies using Quercetin Phytosome also demonstrated meaningful serum uric acid reductions in adults with elevated levels.

Resveratrol has been mechanistically characterized as a xanthine oxidase inhibitor in a 2025 study using kinetics, molecular docking, and animal models, showing reduced serum uric acid in hyperuricemic animals. It suppresses NLRP3 inflammasome and NF-κB in MSU crystal-induced gout models. Polygonum cuspidatum, the primary resveratrol source in TCM, showed the strongest XO inhibitory activity of Chinese anti-gout plant water extracts tested.

A PMC-published study (2017) demonstrated that rose hip extracts inhibit xanthine oxidase (XO) activity in vitro and reduce serum urate levels in a hyperuricemia mouse model. XO is the rate-limiting enzyme in uric acid production and the target of anti-gout drugs. Traditional European herbal medicine also specifically listed rose hip for gout treatment.

Rutin, a quercetin glycoside in buckwheat and citrus, inhibits xanthine oxidase in vitro and lowers serum uric acid in hyperuricemic animal models, reducing it to control levels at certain doses. A 2021 hepatocyte culture study found rutin reduced uric acid production comparably to quercetin. The 2023 Food Frontiers review ranked rutin among flavonoids that decrease uric acid in hyperuricemic animals by more than 50% at certain doses.

Sarsaparilla (particularly Smilax china) has been shown in animal studies to lower serum uric acid levels and enhance the effect of allopurinol. Traditional use for gout spans centuries across global herbal systems. The diuretic action also promotes uric acid excretion. Human trial data are lacking.

A key phenylpropanoid glycoside from S. ningpoensis, acteoside, has demonstrated dose-dependent hypouricaemic effects in a mouse model of hyperuricaemia, reducing serum uric acid levels by 15–33% via inhibition of xanthine dehydrogenase and xanthine oxidase. This represents direct pharmacological evidence linking scrophularia root to uric acid metabolism relevant to gout.

Silybin (silibinin), the principal flavonolignan of milk thistle silymarin, is a confirmed mixed-type xanthine oxidase inhibitor in vitro, also reducing XO-generated superoxide production. The 2023 Food Frontiers review ranked it among flavonoids that decrease uric acid in hyperuricemic animal groups by more than 50% at certain doses—one of the highest-potency natural XO inhibitors in animal models.

Rhizoma Smilacis Glabrae (S. glabra) has been used in TCM for gout for centuries and multiple pre-clinical studies demonstrate xanthine oxidase inhibition and uricosuric effects. Astilbin stereoisomers reduce serum uric acid in hyperuricemic mouse models. A combination study with etoricoxib in acute gouty arthritis showed increased efficacy, providing some clinical-context evidence.

Strawberries are among the richest sources of vitamin C, which has documented uric acid–lowering effects by increasing renal urate excretion. Multiple clinical studies and a meta-analysis support vitamin C supplementation as reducing serum urate; strawberry-derived vitamin C is mechanistically relevant to this pathway. Strawberries are low in purines, making them a safe food for gout-prone individuals.

Sunflower head extract (SHE) demonstrated significant anti-gouty arthritis and antihyperuricemia effects in animal models. It suppressed monosodium urate crystal-induced ankle swelling in rats and reduced uric acid and xanthine oxidase activity in hyperuricemia mice. This represents preclinical scientific evidence from well-designed animal studies.

T. chebula and T. bellirica were evaluated in a randomized, double-blind, placebo-controlled trial in hyperuricemic patients for reduction of serum uric acid levels. Both extracts showed xanthine oxidase inhibitory activity comparable to allopurinol in vitro at relevant concentrations. Traditional use for gout and joint pain is also well-documented.

Turmeric's active compound curcumin has been studied for gout. A small 2025 RCT (n=48 gout patients) found 1,000 mg curcumin/day for 12 weeks reduced uric acid levels, gout flares, and pain. Curcumin inhibits NLRP3 inflammasome and NF-κB, key mediators of gouty inflammation; in animal models, high-dose curcumin inhibits xanthine oxidase and upregulates ABCG2 urate excretion. Results from a separate RCT in asymptomatic hyperuricemia were not superior to placebo, indicating mixed evidence.

Vitamin C lowers serum uric acid by competing with urate at the renal proximal tubule for reabsorption, increasing urinary uric acid excretion. A randomized placebo-controlled trial (n=184) found 500 mg/day for 8 weeks reduced serum urate by 0.5 mg/dL versus placebo. A meta-analysis of 13 RCTs confirmed a significant, modest urate-lowering effect, and a large prospective cohort found men taking ≥1,500 mg/day had a 45% lower gout risk.

A 2022 animal study found zinc intervention reduced serum uric acid and downregulated xanthine oxidase and adenosine deaminase activities in hyperuricemic rats on a high-purine diet, while also favorably modifying gut microbiota. Zinc's role as a superoxide dismutase cofactor may provide secondary anti-inflammatory benefits relevant to gout.

Traditional and folk medicine has long used ACV to 'alkalize the body' and manage gout symptoms. Clinical evidence is very limited; no large RCTs confirm ACV reduces serum uric acid. One small, preliminary double-blind trial (2020) suggested a drop in uric acid with ACV, but findings have not been independently replicated.

Barley grass is documented in traditional medicine and review literature to reduce uric acid levels and alleviate gout symptoms. Its anti-inflammatory flavonoids and antioxidants provide a plausible mechanism, and it is listed as an anti-gout food in review literature. Dedicated human clinical trials are currently lacking.

Birch leaf is traditionally used for gout and uric acid management, with its diuretic action proposed to increase urinary excretion of uric acid. This use is documented in the ESCOP monograph and German Commission E, and is a well-established indication in European phytomedicine. No robust clinical trials specifically demonstrating uric acid lowering by birch have been identified.

Blackberry has been used for gout since ancient Greek physicians prescribed it for this condition, making it one of the oldest documented herbal uses of the plant. Blackberry's vitamin C and quercetin content provide mechanistic support for uric acid reduction, and traditional use is recognized in multiple historical and ethnobotanical records.

Borage has documented traditional use for gout, recorded in multiple herbal sources. The anti-inflammatory properties of borage, particularly GLA-derived eicosanoid modulation, provide a mechanistic basis for potential benefit in gout flares, but no clinical trials have evaluated this.

Boswellia (Indian frankincense) contains boswellic acids that inhibit 5-lipoxygenase, suppressing leukotriene-mediated inflammation central to gout flares. Boswellia dalziellii extracts demonstrated 5-LO inhibitory activity in the PMC 2022 review of anti-inflammatory compounds in gout. Ayurvedic and African traditional medicine have used Boswellia for arthritis and gout for centuries.

Boswellic acids, the active compounds of Boswellia, are specific 5-lipoxygenase inhibitors that suppress leukotriene-mediated inflammation relevant to acute gout. The PMC 2022 gout review cited Boswellia 5-LO inhibition as directly relevant to gout management. Traditional Ayurvedic use for arthritis and inflammatory joint conditions including gout is well-documented.

Bromelain, the proteolytic enzyme from pineapple, is listed by the Arthritis Foundation among herbs with anti-inflammatory properties used for gout alongside turmeric and Devil's Claw. It inhibits COX-2, reduces bradykinin, and modulates cytokines (IL-1β, IL-6, TNF-α) central to MSU crystal-triggered gout inflammation. Clinical trials support its anti-inflammatory and analgesic activity in inflammatory joint conditions.

Gout is one of the most consistently cited traditional uses for buchu in both South African and European herbal medicine. Buchu was used in Europe specifically for gout, documented in formal herbal references. No clinical studies have assessed its effect on uric acid levels or gout episodes in humans.

Burdock root has been used traditionally for gout since at least the early 19th century, as documented in the Annals of Internal Medicine (1930s historical note). European phytotherapy sources state that burdock promotes urinary elimination of uric acid crystals. TCM (Drugs.com) lists gout among classical indications. Human-specific clinical trial evidence is absent.

Celery seed (Apium graveolens) has been used in European and Ayurvedic traditional medicine for centuries to relieve gout and promote uric acid elimination. Phthalide compounds (including 3-n-butylphthalide) have shown uric acid-lowering and anti-inflammatory effects in animal studies. A pilot clinical trial using a combination formula including celery seed in gout patients found reduced plasma uric acid and symptoms over 45 days.

Chickweed is used in traditional herbal medicine to support the elimination of excess uric acid via its diuretic action, making it relevant to gout management. Herbal monographs specifically mention this use. No clinical studies exist.

Chicory has a well-established traditional use across European, South Asian, and Chinese medical traditions for gout and uric acid-related complaints, attributed to diuretic properties and promotion of uric acid excretion. Animal research supports a uricosuric mechanism involving renal urate transporter regulation, but human clinical trials are absent.

Gout is among the historically documented traditional indications for Clematis in both European folk medicine and TCM. It appears in WebMD, RxList, Drugs.com monographs, and ScienceDirect pharmacological reviews citing historical references. No scientific studies have evaluated Clematis for uric acid reduction or gout specifically.

Comfrey has a documented traditional use for gout both topically and historically internally in Western European and North American herbalism. Historical pharmacopeias (Culpeper, Hagers Handbuch) and modern herbal references list gout among comfrey's traditional indications. Rosmarinic acid's anti-inflammatory properties are pharmacologically relevant to gouty joint inflammation. No clinical trial evidence exists.

Corn silk has longstanding traditional use in Chinese and other medical traditions for gout and hyperuricemia. Preclinical studies demonstrate significant uric acid lowering through xanthine oxidase inhibition and improved renal uric acid excretion. Human clinical evidence in gout patients is absent.

Dandelion (Taraxacum officinale) has been used in traditional European, TCM, and North American herbalism as a diuretic to promote renal elimination of uric acid in gout. Animal and in vitro studies support uric acid-lowering and kidney-protective effects. The Arthritis Foundation cites it among herbs herbalists use to reduce swelling and promote uric acid elimination in gout.

Devil's Claw (Harpagophytum procumbens) has been used for centuries in African traditional medicine for gout, arthritis, and musculoskeletal pain. Its active compound harpagoside inhibits COX-2, 5-lipoxygenase, TNF-α, and other inflammatory mediators relevant to gout. Animal studies show chronic administration reduces blood uric acid levels. A combination formula including Devil's Claw reduced uric acid and gout symptoms in a pilot clinical study.

Dog Rose hips have a well-documented traditional use in European folk medicine for gout and urate metabolism disorders. Laboratory evidence (xanthine oxidase inhibition in a mouse model) suggests a mechanistic basis, but no human clinical trials for gout have been conducted.

Historical sources document elderberry as a traditional remedy for gout and rheumatism dating to at least the Middle Ages. Review-level evidence suggests elderberry polyphenols may reduce serum uric acid levels, though one 2005 human study found no change in uric acid after elderberry juice consumption.

Garlic has documented traditional use for gout in multiple ethnobotanical systems including Arabian and South Asian medicine. Scientific literature catalogues gout among garlic's traditional indications, and allicin's antioxidant and uricosuric-adjacent mechanisms are discussed, but controlled clinical trials on uric acid reduction in gout patients are absent.

Goldenrod has longstanding traditional use for gout, documented in folk medicine and historical herbal texts across Europe and North America. Its diuretic action is thought to promote uric acid excretion, and flavonoids/saponins may support this. The German Commission E lists gout among traditional indications. No specific clinical trials on goldenrod for gout or uric acid reduction in humans have been published.

Gravel root is traditionally used for gout and excess uric acid, with the rationale that its diuretic action promotes renal clearance of uric acid. It was cited for gout by Eclectic physicians and in multiple herbal pharmacopeias. No human clinical data exist.

Ayurvedic texts explicitly reference guggul for Vatarakta (gouty arthritis), and Kaisora Guggulu is a classical formulation specifically indicated for gout and elevated uric acid. No human clinical trials for guggul in gout have been published.

Holly leaves and roots are documented in European traditional medicine as diuretics specifically employed for gout and dropsy, conditions associated with fluid accumulation and uric acid excess. No clinical evidence supports this use.

Horseradish has traditional use for gout, documented since Culpepper's 17th-century writings recommending it topically for joint-ache. RxList lists gout as a traditional indication. The diuretic action of sinigrin is proposed to promote uric acid excretion, while the rubefacient action addresses local pain. No clinical trials exist for this specific indication.

Horsetail has a documented traditional use for gout across multiple historical and ethnopharmacological sources. The proposed mechanism involves enhanced uric acid excretion via diuretic action, which could theoretically lower serum urate. No clinical trials have measured uric acid levels or gout outcomes with horsetail supplementation.

Hydrangea root is listed in Traditional Chinese Medicine (TCM) literature as an herb used for gout, attributed to its diuretic and heat-clearing properties, which in TCM theory would facilitate elimination of uric acid. Western folk herbalism similarly records its use for gout. No clinical or pharmacological studies have investigated hydrangea's effect on serum uric acid levels.

Gout is among the classical Ayurvedic indications for T. cordifolia ('Vatarakta'). Preclinical data suggest it inhibits enzymes related to uric acid production and reduces plasma uric acid levels in animal models. Traditional use for gout is documented across Ayurveda, Siddha, and folk systems. No controlled human trials for gout specifically are available.

In Ayurvedic and Siddha medicine, indigo (I. tinctoria) is listed for gout, traditionally attributed to its Virechana (purgative) and anti-inflammatory properties. Ayurvedic texts and encyclopaedias of Indian medicinal plants document this use. No clinical trials exist.

European ethnopharmacology, particularly from France, Greece, Italy, and Serbia, documents the use of S. vulgaris infusions and decoctions as external treatments for gout. This is cited in multiple peer-reviewed sources. No preclinical or clinical data specifically on uric acid modulation by S. vulgaris exist.

Lime has a traditional reputation for dissolving uric acid and relieving gout, attributed to its high citric acid content acting as a solvent for urate crystals. Some scientific support exists for citrate alkalinizing urine and reducing serum uric acid, but lime-specific human gout trials are lacking.

Momordica charantia is documented in traditional medicine in Asia and Africa for gout. Preclinical animal evidence shows M. charantia extract can reduce serum uric acid levels. Human clinical data are absent.

Gout and uric acid-related conditions are documented traditional applications for Plantago in multiple European and Asian folk medicine systems. The diuretic effect of P. major supports urate excretion. Anti-inflammatory mechanisms are relevant to gout flares. No human clinical data for gout specifically with Plantago has been published.

Traditional ethnobotanical records, including a Pharmacognosy Journal review, document P. marsupium's use for gout. The plant's anti-inflammatory activity is mechanistically relevant to gout, though no uric-acid–specific preclinical or clinical data have been found.

Punarnava is traditionally used in Ayurveda for gout via formulations such as Punarnavadi Guggulu. Its diuretic action mechanistically supports uric acid excretion. Preclinical nephroprotection studies show normalization of elevated uric acid in kidney tissue. No human trials specifically for gout or serum urate reduction have been conducted.

Gout is a consistently listed traditional indication for red clover across herbalism traditions in Europe and Asia. Multiple clinical monographs document its traditional use for gout and associated joint pain. No clinical trial evidence specifically evaluating red clover for gout or uric acid reduction has been identified.

Traditional Tibetan medicine uses R. cordifolia specifically for blood disorders and 'excess heat in the kidneys,' and classical Ayurvedic texts note its use in urinary disorders and blood purification that encompasses uric acid-related conditions. Its diuretic and anti-inflammatory properties are traditionally relevant to gout management.

Sage is documented in folk medicine traditions of Asia, Latin America, and Europe for the treatment of gout. A preclinical study showed reduced uric acid in diabetic rats given sage extract. No human RCTs for gout or uric acid reduction could be identified.

Salicin-containing willow bark has a documented traditional use for gout, with historical use of salicylates specifically for gouty arthritis. Multiple pharmacological references list gouty arthritis among its uses. No modern RCTs isolating salicin for uric acid reduction or acute gout attacks have been identified.

T. cordifolia is documented in Ayurvedic ethnopharmacological literature as a traditional remedy for gout, often combined with other herbs. PMC 5018348 explicitly states it is commonly used in combination with other herbs to treat gout and rheumatoid arthritis.

Tribulus is traditionally used in Ayurveda (gokshura) for managing elevated uric acid and rheumatic pain. Its diuretic action may promote renal uric acid excretion. Traditional use for gout and joint stiffness is documented in multiple traditional systems, but no clinical RCT exists.

Gout alleviation is explicitly cited as a folk medicine claim for wheatgrass in peer-reviewed immunology literature (PMC 2013). Traditional use is well-documented. No human clinical trial has measured wheatgrass effects on serum uric acid levels.

Hippocrates and Dioscorides specifically recommended willow bark as a remedy for gout in ancient Greek medicine. Willow bark's anti-inflammatory and analgesic properties provide a pharmacological basis for relieving gout-associated pain and swelling. It is listed in multiple contemporary references as used for gout. No clinical trials on white willow bark for gout or uric acid levels have been conducted.

Ancient Greek medicine (2,400+ years ago) used willow extracts specifically to treat gout, and it is listed in ethnobotanical and traditional pharmacopeial sources for this purpose. However, the 2012 American College of Rheumatology guidelines on gout management explicitly voted that willow bark is inappropriate for treating an acute gout attack, indicating no supportive clinical evidence. The relationship is therefore traditional in nature.

Wood betony has documented traditional use for gout, appearing in Renaissance pharmacy including Pistoia powder. Its diuretic and anti-inflammatory properties are the proposed mechanisms. No modern scientific evidence exists.

Gout — caused by uric acid crystal deposition — is not a directly studied indication for yucca, but the plant's anti-inflammatory properties are mechanistically relevant to reducing the inflammatory flare of gout attacks. Yucca's NFκB and COX inhibition would suppress acute gouty inflammation. Some traditional sources group gout under the broader rheumatic conditions for which yucca is used.